Aegerion Pharmaceuticals CEO Marc Beer's 2015 pay slips 14% to $3.6M
Aegerion Pharmaceuticals reports 2015 executive compensation
By ExecPay News
Published: April 29, 2016
Aegerion Pharmaceuticals reported fiscal year 2015 executive compensation information on April 29, 2016.
In 2015, eight executives at Aegerion Pharmaceuticals received on average a compensation package of $1.8M, a 1% decrease compared to previous year.
Marc Beer, Chief Executive Officer, received $3.6M in total, which decreased by 14% compared to 2014. 57% of Beer's compensation, or $2M, was in option awards. Beer also received $370K in salary, $858K in stock awards, as well as $344K in other compensation.
Gregory Perry, Chief Financial & Administration Officer, received a compensation package of $3M. 90% of the compensation package, or $2.7M, was in option awards.
Mark Sumeray, Chief Medical Officer, earned $1.8M in 2015, a 9% increase compared to previous year.
Martha Carter, Chief Regulatory Officer, received $1.6M in 2015, which increases by 370% compared to 2014.
Mary Weger, former Chief Performance Officer, earned $1.5M in 2015, a 9% decrease compared to previous year.
Mark Fitzpatrick, Chief Financial Officer, received $1.2M in 2015, which decreases by 20% compared to 2014.
Sandford D. Smith, Chief Executive Officer, earned $1.1M in 2015.
David Aubuchon, Chief Financial Officer, received $883K in 2015.
Related executives
Sandford Smith
Aegerion Pharmaceuticals
Chief Executive Officer
Marc Beer
Aegerion Pharmaceuticals
Chief Executive Officer
Gregory Perry
Aegerion Pharmaceuticals
Chief Financial & Administration Officer
David Aubuchon
Aegerion Pharmaceuticals
Chief Financial Officer
Mark Fitzpatrick
Aegerion Pharmaceuticals
Chief Financial Officer
Mark Sumeray
Aegerion Pharmaceuticals
Chief Medical Officer
Mary Weger
Aegerion Pharmaceuticals
former Chief Performance Officer
Martha Carter
Aegerion Pharmaceuticals